Skip main navigation
Close Drawer MenuOpen Drawer Menu

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
CorrectionFull Access

CORRECTION

Published Online:1 Nov 2016https://doi.org/10.1176/appi.ajp.2016.17311correction

When the article “The Risk of Treatment-Emergent Mania With Methylphenidate in Bipolar Disorder” by Alexander Viktorin et al. (doi:10.1176/appi.ajp.2016.16040467) was originally posted online on Oct. 3, 2016, the hazard ratio reported in the Results section for mania during months 0-3 in patients receiving methylphenidate monotherapy should have been 6.7. The hazard ratio was corrected and the article reposted on Oct. 17, 2016. The article will appear as intended in its print publication in an upcoming issue as well as in its online posting as part of that issue.